261 related articles for article (PubMed ID: 12080637)
1. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
Fu XM; Yang QX; Shao CK; Feng ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
4. [Study on relationship between apoptosis and proliferation of cells in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Chen R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):120-2. PubMed ID: 10681820
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas.
Beerheide W; Tan YJ; Teng E; Ting AE; Jedpiyawongse A; Srivatanakul P
Biochem Biophys Res Commun; 2000 Jun; 273(1):54-61. PubMed ID: 10873563
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Osada S; Saji S; Kuno T
J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of cell cycle and apoptotic proteins in human liver pathologies.
Mitselou A; Karapiperides D; Nesseris I; Vougiouklakis T; Agnantis NJ
Anticancer Res; 2010 Nov; 30(11):4493-501. PubMed ID: 21115898
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
11. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
Caruso ML; Valentini AM
Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
[TBL] [Abstract][Full Text] [Related]
14. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
15. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
16. Bcl-xL overexpression in human hepatocellular carcinoma.
Watanabe J; Kushihata F; Honda K; Mominoki K; Matsuda S; Kobayashi N
Int J Oncol; 2002 Sep; 21(3):515-9. PubMed ID: 12168094
[TBL] [Abstract][Full Text] [Related]
17. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
Mun KS; Cheah PL; Baharudin NB; Looi LM
Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
[TBL] [Abstract][Full Text] [Related]
19. [Expression of P53, bcl-2 protein and proliferating cell nuclear antigen in cutaneous squamous cell carcinoma].
Chen ML; Yan LX; Yu GY
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):513-4. PubMed ID: 12212140
[No Abstract] [Full Text] [Related]
20. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]